Loading stock data…
Avita Medical, Inc. (RCEL)
$4.61
Market ClosedLast close Jul 24
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AVITA Medical, Inc. in the Healthcare sector is trading at $4.61 with a market capitalization of $128M. Wall Street consensus targets $9.05 (2 analysts), implying a +96.3% move over the next 12 months. The stock is currently 35% below its 52-week high of $7.12, remaining 10.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +96.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $19.25M↑ | $17.61M↑ | $17.06M↓ | $18.42M↓ | $18.51M |
| Gross Profit | $15.73M↑ | $14.31M↑ | $13.88M↓ | $14.95M↓ | $15.68M |
| Operating Income | -$8.80M↑ | -$10.41M↓ | -$9.15M↑ | -$11.15M↑ | -$11.83M |
| Net Income | -$10.61M↑ | -$11.62M↑ | -$13.19M↓ | -$9.92M↑ | -$13.86M |
Peer Comparison
JNJUNHPFE
Fundamentals
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harves...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$128.03M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.90
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
195.71%
Volume
Today's trading volume
81,578
Recent News
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum
AVITA Medical’s fair value estimate has been reset from US$6.98 to US$9.00 per share, giving investors a fresh reference point for how analysts are framing the stock today. Behind this change, recent commentary highlights optimism around RECELL adoption, revenue momentum, and cash flexibility, while also flagging that execution against guidance and liquidity remain key watchpoints. As you read on, you will see how these shifting pieces of the AVITA Medical story fit together and what to watch...
Avita Medical (RCEL) Upgraded to Buy: Here's Why
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Undervalued Small Caps With Insider Buying Across Regions
The United States market has experienced a flat week, yet it has shown a robust 27% increase over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this context of growth and stability, identifying stocks that are currently undervalued can offer potential opportunities for investors seeking to capitalize on insider confidence and regional strengths.
AVITA Medical, Inc. Q1 2026 Earnings Call Summary
Moby summary of AVITA Medical, Inc.'s Q1 2026 earnings call
AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
AVITA Medical Inc (AVHHL) reports a 4% year-over-year revenue increase and reaffirms full-year guidance, while addressing margin pressures and cash flow challenges.